Type of Study:

Interventional

Study Design:

Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Biomarker

Outcome Description:

success to evaluate at least one molecular analysis in tumor tissues (prostate and/or metastatic site) AND in CTC

Outcome Time Frame:

assessed at the end of recruitment, up to 2 years

Safety Issue:

No

Authority:

France: Agence Nationale de Sécurité du Médicament et des produits de santé

Study ID:

2012-A00668-35

NCT ID:

NCT01786031

Start Date:

December 2012

Completion Date:

December 2015

Related Keywords:

• Metastatic Castration Resistant Prostate Cancer Patients
• Prostatic Neoplasms